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Background: Cynodon dactylon, a valuable medicinal plant, is widely used in Iranian folk medicine for the
treatment of various cardiovascular diseases such as heart failure and atherosclerosis. Moreover, its anti-diabetic,
anti-cancer and anti-microbial properties have been also reported. Concerning the critical role of angiogenesis in
the incidence and progression of tumors and also its protective role in cardiovascular diseases, we investigated the
effects of the aqueous extract prepared from the rhizomes of C. dactylon on vascular endothelial growth factor
(VEGF) expressions in Human Umbilical Vein Endothelial Cells (HUVECs) and also on angiogenesis in carrageenan
induced air-pouch model in rats.
Methods: In the air-pouch model, carrageenan was injected into an air-pouch on the back of the rats and following
an IV injection of carmine red dye on day 6, granulation tissue was processed for the assessment of the dye
content. Furthermore, in an in vitro study, angiogenic property of the extract was assessed through its effect on
VEGF expression in HUVECs.
Results: Oral administration of 400 mg/kg/day of the extract significantly increased angiogenesis (p < 0.05) and
markedly decreased neutrophil (p < 0.05) and total leukocyte infiltration (p < 0.001) into the granulation tissues.
Moreover, the extract increased the expression of total VEGF in HUVECs at a concentration of (100 μl/ml).
Conclusion: The present study showed that the aqueous extract of C. dactylon promotes angiogenesis probably
through stimulating VEGF expression.
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Recently, medicinal plants have been largely considered as
the harmless alternate to synthetic drugs, especially due to
their more safety and less side effects as compared to
the chemical drugs. Cynodon dactylon, also known as
Bermuda grass, is a perennial grass native to the warm
temperate and tropical regions [1]. In North West of Iran,
C. dactylon is known as “Chayer” and the aqueous extract
of its rhizomes is widely used in the treatment of cardio-
vascular disorders such as atherosclerosis and heart failure
due to its hypolipidemic and cardiac tonic effects [2,3].* Correspondence: soraya.h@umsu.ac.ir
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unless otherwise stated.However, despite the presence of several reports on the
anti-diabetic, anti-microbial [4], hypolipidemic [5], hepato-
protective [6], anti-emetic and anti-inflammatory [7] prop-
erties of C. dactylon, the probable role of angiogenesis as
the mechanism involved in cardioprotective effect of the
plant has remained largely elusive.
Angiogenesis, the formation of new blood vessels from
pre-existing capillaries, plays an important role in many
physiologic and also pathologic processes including
cancer, ischemic heart diseases and chronic inflammation
[8,9]. Moreover, since the therapeutic interference with
angiogenesis offers a valuable tool for clinical application
in several pathological conditions, much attention has
been paid on medications or compounds that alter the
gene expression profile of vascular endothelial cell growthThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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key pro-angiogenic molecules [10]. In some cases such as
heart failure or cardiac ischemia-reperfusion, stimulation
of angiogenesis is beneficial and can be considered as a
target to improve the disease condition, however in several
other diseases such as cancer, atherosclerosis, rheumatoid
arthritis and diabetic retinopathy, excessive angiogenesis is
part of the pathology and progression of the disease
[9-11]. Therefore, stimulation or inhibition of angiogenesis
to reach therapeutic purpose is dependent on the type of
the disease.
Marappan and Subramaniyan [12] assessed anti-tumor
effects of the methanolic extract of C. dactylon leaves
against ascetic lymphoma (ELA) in Swiss albino mice. The
results showed that the plant possesses significant anti-
tumor effects [12]. Another study by Krishramoorthy and
Ashwini [13] also reported anti-cancer effects of C. dacty-
lon in Swiss albino mice. The hydroalcoholic extract from
rhizomes of C. dactylon has been shown to have strong
protective effect on right heart failure in rats, in part by
improving cardiac function and increasing the contractile
force [2]. In another study this effect was also attributed to
its anti-arrhythmic activity [14]. The plant also increased
heart beat rate in a study on zebrafish with a potency
greater than that of betamethasone [15].
As stated above, C. dactylon has been proven to be an
effective cardiovascular agent by several studies; however
almost none of the studies have precisely investigated
the underlying mechanisms through which this plant ex-
erts its effects on the cardiovascular system. The authors
speculate that such beneficial effects of C. dactylon
might be at least partly associated with its probable ef-
fects on angiogenesis. Since there have been no studies
conducted so far on the possible effects of C. dactylon
on angiogenesis, the present study was carried out to in-
vestigate the possible angiogenic activity of the plant in
human umbilical vein endothelial cells (HUVECs) and
also in an air-pouch model in rats.
Materials and methods
Extract preparation
C. dactylon was purchased from a traditional herbal mar-
ket and the genus and species was authenticated at the
Herbarium of Botany, Faculty of Pharmacy, Urmia, Iran.
The rhizomes of the plant were dried in shade and
coarsely ground to powder using an automatic grinder.
200 g of the powder was mixed in 2 L of distilled water
and placed on a magnet stirrer at a temperature of 50°C
for three days. The mixture was then filtered three times
using the Wattman’s paper. The solution was finally evap-
orated to dryness for 12 hrs at 70°C. The total amount of
the crude extract obtained was 34 g. The extract was di-
luted with water in order to be given orally by gavage
needle.Preliminary phytochemical screening
Qualitative phytochemical analysis of C. dactylon aque-
ous extract was conducted following the standard proce-
dures as described by Harborne [16], Sofowora [17] and
Trease and Evans [18].
Alkaloids
Crude extract was mixed with 2 ml of 1% HCl and
heated gently. Mayer’s reagent was then added to the
mixture. Turbidity of the resulting precipitate is as evi-
dence for the presence of alkaloids.
Anthocyanins
2 ml of aqueous extract was added to 2 ml of 2 N HCl
and NH3. Manifestation of pink-red turning blue-violet
indicates the presence of anthocyanins.
Coumarins
3 ml of 10% NaOH was added to 2 ml of aqueous
extract, formation of yellow color indicates the presence
of coumarins.
Flavonoids
Crude extract was mixed with few fragments of magne-
sium ribbon and concentrated HCl was added drop wise.
Appearance of pink scarlet color after few minutes indi-
cates the presence of flavonoids (Shinoda test).
Saponins
Crude extract was mixed with 5 ml of distilled water in
a test tube and shaken vigorously to obtain a stable per-
sistent froth. The frothing is then mixed with 3 drops of
olive oil and for the formation of emulsion which indi-
cates the presence of saponins.
Tannins
Crude extract was mixed with 2 ml of 2% solution of
FeCl3. Observed blue-green or black coloration indicates
the presence of tannins.
Assay for in vitro antioxidant activity
The free radical scavenging capacity of the extract was mea-
sured from the bleaching of the purple-colored methanolic
solution of 2,2-diphenyl-1-picrylhydrazyl)DPPH), a rou-
tinely practiced material for the assessment of antiradical
properties of different compounds [19]. The stock concen-
tration of the C. dactylon aqueous extract (1 mg/mL) was
prepared followed by dilution to reach for concentrations
5 × 10−1, 2.5 × 10−1, 1.25 × 10−1, 6.25 × 10−2, 3.13 × 10−2
and 1.56 × 10−2 mg/mL of the extract. The acquired con-
centrations in the same volumes of 2 mL were added to
2 mL of a 0.08 % of DPPH solution [20-22]. Later than a
30 min of incubation at 30°C, the absorbance of each solu-
tion was read against a blank sample at 517 nm (Shimadzu
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value was noted for each sample after the test was carried
out in triplicate. Besides, as the positive control the same
procedure was gone over with quercetin. The inhibition
percentage of DPPH free radicals of by the aqueous
extract was calculated as follows:
R %ð Þ ¼ 100  A blank – A sampleð Þ=A blank½ 
Herein, “A blank” stands for the absorbance value of
the control reaction and “A sample” is the absorbance
value for each sample. Additionally, RC50 value, the con-
centration of the extract reducing 50% of the DPPH free
radicals, was calculated from the graph of inhibition per-
centages versus concentrations of C. dactylon extract in
mg/mL.
Assay for total phenolics content
Total phenolic constituents of the C. dactylon aqueous
extract was verified by assigning Folin-Ciocalteu reagent
and gallic acid as the standard compound for phenolics,
the same procedure as given in the literature [23-26].
Briefly, 0.5 mL of the extract was mixed with 5 mL of
Folin-Ciocalteu reagent (10% v/v in distilled water) with
4 mL of 1 M aqueous Na2CO3 after 5 min and the mix-
ture was allowed to stand for 15 min with intermittent
shaking. The absorbance of the blue color produced
by the reaction was measured using a UV/visible spec-
trophotometer (Shimadzu 2100 - Japan) at 765 nm. The
standard curve was prepared using 25–300 μg/mL solutions
of gallic acid in methanol: water (50:50, v/v). Eventually, the
value for total phenol content of the C. dactylon extract was
represented in terms of gallic acid equivalent which is a
common reference compound.
Animals
Albino Wistar rats (220-250 g) were used in this study.
Rats were housed at constant temperature (20 ± 1.8°c)
and relative humidity (50 ± 10%) in standard polypropyl-
ene cages, eight per cage, under a 12 L:12D schedule
and were allowed food and water freely. This study was
performed in accordance with the Guide for the Care
and Use of Laboratory Animals of Urmia University of
Medical Sciences, Urmia-Iran.
In vivo angiogenesis assay
Rats were divided into 5 groups consisting 8 rats each.
Rats in group 1 (carrageenan) received intra-pouch injec-
tion of carrageenan and normal saline as vehicle (0.5 ml)
was given orally. Rats in group 2 received intra-pouch in-
jection of carrageenan and intraperitoneal injection of
dexamethasone. Rats in group 3 to 5 received intra-pouch
injection of carrageenan and cynodon dactylon extract
was given orally at doses 100, 200 and 400 mg/kg/day. Foranalyzing the effects of the aqueous extract of C. dactylon
on in vivo angiogenesis, the air-pouch model described by
Gosh et al. [8] was used with minor modifications. Briefly,
rats (n = 8) were lightly anesthetized with diethyl ether, the
back was shaved and then swabbed with 70% ethanol.
Subsequently, 8 ml of sterile air was injected subcutane-
ously on the back of the animals to make an air-pouch
oval in shape. Twenty four hours later, 4 ml of a 1% (w/v)
solution of carrageenan (Sigma Co; USA) in saline was
injected into the air-pouch under light diethyl ether
anesthesia. The carrageenan solution had been sterilized
by autoclaving at 121°C for 15 min and supplemented
with penicillin G potassium and streptomycin sulfate
(JaberEbne – e- Hayyan, Iran) (0.1 mg/ml of the solu-
tion) after cooling to 40–45°C. The aqueous extract of
C. dactylon was administered orally at doses of 100,
200 and 400 mg/kg/day and dexamethasone as a standard
anti-inflammatory agent (10 mg/kg/day) was injected in-
traperitoneally, a day before and for 6 days after carra-
geenan injection.Determination of angiogenesis in granulation tissue
Six days after carrageenan injection, measurement of the
angiogenesis in the granulation tissue was carried out
using carmine dye, as an indicator of angiogenesis, accord-
ing to the methods described by Gosh et al. [8] with slight
modification. Briefly, the rats were anesthetized by intra-
peritoneal injection of a mixture of ketamine (60 mg/kg)
and xylazine (10 mg/kg). Then 3 ml of 5% (w/v) carmine
dye (Sigma Co; USA) in 5% (w/v) gelatin (Sigma Co; USA)
in saline at 37°C was injected into the jugular vein of each
rat. The carcasses were chilled on ice for 3 hrs and then
the entire granulation tissue was dissected and weighted.
After being washed with PBS (PH 7.4) the whole granula-
tion tissue was homogenized in two volumes of 0.5 mM
sodium hydroxide using a T25 basic homogenizer (IKA
labortechnik, Gremany) for 4 min at 10000 g on an ice
bed. The tissue homogenate was centrifuged at 3000 g and
4°C for 45 min and 500 μl of the supernatant was diluted
2-fold with 0.5 mM sodium hydroxide and centrifuged
again. Then 100 μl of the supernatant was diluted with
900 μl of 0.5 mM sodium hydroxide and the carmine dye
content was assessed spectrophotometrically at a wave-
length of 490 nm. For histopathological visualization of
the granulation tissues, the tissues were fixed in 10% (v/v)
formalin in PBS for 48 hrs at 4°C. The samples were
dehydrated by continuous immersion in 70% (v/v) etha-
nol for 48 hrs, 90% (v/v) ethanol for 48 hrs, and pure
ethanol for 48 hrs. After dehydration, the samples were
cleared by their immersion in the cedarwood oil (Sigma
Co; USA) for 14 days. Retention of carmine dye within
the vascular bed was observed with a light microscope
(40× magnification).
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tissue weight, total leukocyte infiltration along with
lymphocyte and neutrophil percentage in the pouch exudates
Six days after the carrageenan injection, total pouch fluid
was collected, the volume was measured and the entire
granulation tissue was dissected and weighted. The total
leukocyte count was determined in a neubauer chamber
and the differential cell count was determined by micro-
scopic counting of Gimsa stained slides.
In vitro angiogenesis assay
The expression changes in cytoplasmic and surface levels of
VEGF in PBS or extract treated HUVECs were determined
using a PAS flow cytometer (Partec GmbH, Germany).
Briefly, human umbilical vein endothelial cells (HUVECs)
were cultured at 37°C and 5% CO2 in low-glucose Dulbecco’s
Modified Eagle’s Medium (LG-DMEM) supplemented by
Supplement Mix (PromoCell) and10% fetal bovine serum
(FBS). At second passage cells were treated with PBS
(100 μl/ml) and C. dactylon extract (100 μl/ml). After
12 hrs using trypsin/EDTA (Ethylenediaminetetraacetic
acid) solution (0.25%), cells were detached and then
washed twice in PBS. The collected cells were permea-
blized with 0.1% PBS-Tween for 20 min. After incubation
in 1× PBS/10% normal goat serum/0.3 M glycine to block
non-specific interactions, unconjugated rabbit anti human
VEGF antibody (abcam) was added. Subsequently, staining
was performed using secondary goat anti-rabbit IgG PE
antibody. The total 20000 events for each sample were ac-
quired. Flow max software was used for data analysis.
Statistical analysis
Data were presented as mean ± standard error of the mean
(SEM) and were analysed using one-way-ANOVA to make
comparisons between the groups. If the ANOVA analysis
indicated significant differences, Student–Newman–Keuls
post test was performed to compare the mean values
between the treatment groups and the control group.




Phytochemical compounds such as alkaloids, anthocya-
nins, coumarins, flavonoids, saponins, tannins and phen-
olic compounds were screened in the C. dactylon aqueous
extract. Availability of these compounds, important sec-
ondary metabolites, has been tabulated in Table 1. AmongTable 1 Phytochemical analysis, DPPH radical scavenging cap
rhizomes extract
Alkaloids Anthocyanins Coumarins Fla
C. dactylon extract + - + -the selected compounds alkaloids, coumarins, saponins
and some phenolics, were present in the plant which could
be responsible for the medicinal values of the respective
plant. Moreover, the amount of total phenolic compounds
in the C. dactylon aqueous extract established through
Folin Ciocalteu method was calculated as gallic acid
equivalent. The equation [Sample absorbance = 0.0067 ×
gallic acid (μg) + 0.0132, (R2: 0.987)] achieved by the
standard gallic acid graph was applied in calculation of the
phenolic compounds concentration. Subsequently, the
content for C. dactylon total phenolics showed the value
39.82 mg of gallic acid equivalent in g of plant extract
(Table 1). The findings of the antioxidant activity for C.
dactylon aqueous extract, accomplished by the DPPH
method, revealed sensible values in vitro. Regarding the re-
sults for the DPPH radical scavenging antioxidant assay, C.
dactylon extract exhibited pleasant antioxidant activity with
RC50 values of 0.70 mg/ml for the extract and 3 μg/mL for
the control quercetin (Table 1). Quantitative phytochemical
analysis revealed that the plant contained phenolic com-
pounds a class of phytochemicals that could be responsible
for the antioxidant and free radical scavenging effect of the
plant material.
Effects of the aqueous extract of C. dactylon on
angiogenesis in granulation tissue
Six days after the injection of carrageenan solution into the
air-pouch, a dissectible granulation tissue was formed in
the subcutaneous tissue. Following intravenous injection of
carmine red dye to the anaesthetized animals, the dye was
accumulated in the granulation tissue and the amount of
the dye was assessed as an index of angiogenesis. As shown
in Figure 1, oral administration of the aqueous extract of
C. dactylon (400 mg/kg) produced a significant (P < 0.05)
increase in angiogenesis. In agreement with these find-
ings, vascular network formation was also stimulated
by C. dactylon as shown in Figure 1 (upper trace; right).
Effects of the aqueous extract of C. dactylon on pouch fluid
volume, leukocyte Infiltration and granulation tissue weight
The treatment of rats with oral administration of the
aqueous extract of C. dactylon at doses of 100, 200 and
400 mg/kg which was started one day before the intra-
pouch injection of carrageenan and continued for 6 days,
dose dependently reduced neutrophil (p < 0.05) and total
leukocyte (p < 0.001) recruitment whereas increased lym-
phocyte recruitment into the exudates (Table 2). In con-
trast, administration of C. dactylon dose dependentlyacity and total phenols content of C. dactylon aqueous
vonoids Saponins Tannins Total phenols DPPH (IC50)
++ - 39.82 mg/g 0.70 mg/ml
Figure 1 Upper trace: Effects of the aqueous extract of C. dactylon (400 mg/kg) on angiogenesis in granulation tissue versus positive
control (carrageenan; left) in the air pouch model of angiogenesis in rats. Lower trace: The effect of oral administration of aqueous extract
of C. dactylon on carmine dye content (as an index of angiogenesis) in granulation tissue in the air pouch model of angiogenesis in rats. Cyno:
Cynodon dactylon, Carrageen: Carrageenan. Data represented as mean ± SEM. N = 6. *P < 0.05 and ***P < 0.001 vs control group (Carrageenan).
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weight in comparison to the carrageenan group (Figure 2).
Dexamethasone was used as a positive control which sig-
nificantly reduced total leukocyte accumulation in the ex-
udate, pouch fluid volume and granulation tissue weight
compared to the carrageenan group (Table 2, Figure 2).
Effects of the aqueous extract of C. Dactylon on VEGF
expression in human umbilical vein endothelial cells
(HUVEC)
The results obtained from flow cytometric analysis
showed the increased expression of total VEGF (both in
cytoplasmic and surface levels) in HUVECs treated with
the aqueous extract of C. dactylon as compared to thoseTable 2 Effect of the aqueous extract of C. dactylon on leukoc




20 ± 1 12 ± 0.33* 22 ± 1.2
Lymphocyte
percentage
58 ± 2.8 50 ± 1.8 57 ± .32
Total leukocyte (105) 895 ± 6.4 498 ± 15.2*** 635 ± 14.3***
Data represented as mean ± SEM. N = 6. *P < 0.05 and *** P < 0.001 vs control group
test. Carrageen: Carrageenan; Cyno: Cynodon dactylon.treated with PBS. Three experiments were performed and
12% increase in expression of VEGF was detected in
extract-treated cells as compared to the PBS-treated ones
(Figure 3).
Discussion
Overall, as far as we know, the long history of use and
prevailing reputation of many types of natural resources,
particularly higher plant species, among the nations are
impressive. More recently, herbal medicines have been
identified as sources of various phytochemicals, many of
which possess different countless activities. Accordingly,
C. dactylon signifying to have medicinally valuable sec-
ondary metabolite types of phytochemicals like alkaloids,ytes recruitment into the pouch exudate




17 ± 3 13 ± 2*
59 ± 4.4 67 ± 3.7
629 ± 33*** 523 ± 19.1***
(Carrageenan) using one way ANOVA with Student-Newman-Keuls post-hoc
Figure 2 Effect of the aqueous extract of C. dactylon at various doses on pouch fluid volume and granulation tissue weight 6 days
after carrageenan injection. Cyno: Cynodon dactylon, Carrageen: Carrageenan. Data represented as mean ± SEM. N = 6–8. *p < 0.05 and
***p < 0.001 versus the carrageenan group.
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have a role in angiogenesis.
Nonetheless, further research is required to meet the
challenges of isolation and structural elucidation of the
major active compounds in the plant for identifying an
efficient natural medicine which is reliant on a better
understanding of the association between chemical con-
stituents and biological properties of natural resources.
In this time of increasing requisite for effective, afford-
able health promotion and treatment strategies for our
growing populations and enlarging health problems, the
history and reputation of herbal medicines must be ex-
amined in a rigorous and scientific way which may be
translated into clinical benefit.
C. dactylon has been widely used in the traditional
medicine of Iran and other countries for the treatment of
several cardiovascular conditions such as heart failure [2],
and arrhythmias [14]. Moreover, various pharmacologicalFigure 3 The expression change of VEGF in HUVECs by flow cytometr
control and the expression changes following treatment with C. dactylon e
treated HUVECs has been shown as compared to the PBS treated ones. Hiseffects of the plant have been proven in several studies
[27]. Examples of these effects include analgesic and anti-
pyretic [28], negative ionotropic and negative chronotropic
effects [29], anti-arthritic, and anti-inflammatory activities
[30]. Although promotion of angiogenesis has been a
therapeutic strategy in the treatment of cardiovascular dis-
eases such as ischemic heart disease; however, it can be
part of the pathogenesis of several other diseases such as
cancer [9,10].
The present study was carried out to evaluate the possible
effects of C. dactylon on angiogenesis which thought to me-
diate the part of beneficial effects of the plant in cardiovas-
cular conditions. Accordingly, the possible angiogenic effect
of the plant was assessed in both Carrageenan-induced air-
pouch model as an in vivo and human umbilical vein endo-
thelial cells as an in vitro models. The results demonstrated
that the constituents present in the aquatic extract of the
plant have the potential to increase angiogenesis probablyic procedure. The expression level of VEGF in PBS treated cells set as
xtract compared to it. The increased expression of VEGF in extract
tograms are representative of three separate experiments.
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angiogenesis parameters including exudate volume and
granulation tissue weight were increased dose dependently
following the administration of the extract. These results
were accompanied with the decreased total leukocyte and
neutrophil infiltration into the air-pouch. Since decreasing
total leukocyte and neutrophil count indicates the anti-
inflammatory effect of C. dactylon the obtained results were
parallel to the findings of the previous studies [7]. However,
the extract of C. dactylon exerts an anti-inflammatory effect
against acute inflammation, while increasing angiogenesis. It
has been already shown that simultaneous administration of
two different substances may upregulate the angiogenic re-
sponses, while downregulating the inflammatory responses
[31]. The same effect can be also attributed to different con-
stituents present in the aqueous extract of the plant.
In vitro study on the effect of C. dactylon on the ex-
pression of VEGF in human umbilical vein endothelial
cells revealed that there might be a positive correlation
between the angiogenic effect of the plant and its ability
to increase VEGF expression. This might be the possible
underlying mechanism through which the plant exerts
its effect. It has been also shown in several studies that
the extract of C. dactylon possesses significant anti-
tumor activities [32,33]. As noted earlier, angiogenesis
plays a central role in the pathogenesis of neoplastic dis-
eases [34], however the exact mechanism(s) responsible
for such effect of the plant is not yet clearly understood.
In the mentioned studies, the sole reversal effects of the
plant against undesired consequences of tumors [12]
and its anti-oxidant properties [16] have been partly at-
tributed to this effect of the plant without adequate
evaluation of other mechanisms affecting tumor growth.
For instance, none of these studies have evaluated the
in vivo angiogenesis changes of the tumors affected by
the administration of the extract. Based on the findings
of the present study which indicate the potential of the
plant to promote angiogenesis at high doses, it has to be
taken into consideration that the plant might contain
unsafe agents which may aid in the growth of the tumor
through increasing the tumor angiogenesis. This is prob-
ably the first study that reveals an unsafe aspect of this
plant in contrast to its beneficial properties previously
shown in anti-cancer studies.
Conclusion
To the best of our knowledge, this is the first study show-
ing the angiogenic property of the aquatic extract of C.
dactylon. Based on these findings, C. dactylon is suggested
as a potential source of angiogenic compounds, the effects
of which might be attributable to its increasing effect on
the expression of VEGF, a growth factor mainly involved
in angiogenesis. Accordingly, this plant can be used in
the development of novel herbal medicines for theamelioration of the consequences of conditions such as is-
chemic heart disease, and other cardiovascular complica-
tions. Our findings are in contrast with the results of
previously conducted studies on the anti-tumor effects of
C. dactylon, indicating that in addition to its beneficial ef-
fect as an anti-cancer source, it might be a toxic agent due
to increasing tumor angiogenesis. Therefore, critical
care should be taken on the safety of the plant to be in-
troduced as an anti-tumor agent. Indeed, further studies
are required to clarify the precise underlying mechanisms
and to identify the safe aspects of the plant to be employed
as a therapeutic source.
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